OPTI CAPITAL MANAGEMENT LP
Q1 2025 Form 13-F

NEW YORK, NEW YORK
CIK 0001738654 · CRD 292742 · SEC-registered investment adviser
$1.6B Reported Value Total

OPTI CAPITAL MANAGEMENT LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $2,505,542,111, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
1 fund · $657.4M gross asset value
Hedge Fund: $657.4M
Source: Form ADV filed 2026-03-30
Reported value
$1.6B
Quarter over quarter
-0.5%
Holdings
2
Top-10 concentration
46.3%

Key People

Form ADV owners & control persons
Xiuping Li
LIMITED PARTNER, FOUNDER
Thomas Patrick Kennedy
CFO/COO/CCO

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2025 13F record

Q1 2025 13F filing summary

Q1 2025 Form 13F portfolio summary
Period of report March 31, 2025
Filed May 15, 2025
Form 13F-HR
Reported value $1.6B
Positions 2
Change in reported value -26.9%
New positions 11
Exited positions 24
Position turnover 134.6%
Top-10 concentration 46.3%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 16, 2026
0 $2.0B
Q2 2026 13F
Filed Aug 14, 2026
0 $1.6B
Q1 2026 13F
Filed May 15, 2026
0 $1.4B
Q4 2025 13F
Filed Feb 17, 2026
0 $1.4B
Q3 2025 13F
Filed Nov 14, 2025
0 $1.6B
Q2 2025 13F
Filed Aug 14, 2025
0 $1.8B
Q1 2025 13F
Filed May 15, 2025
2 $1.6B
Q4 2024 13F
Filed Feb 14, 2025
2 $2.2B
Q3 2024 13F
Filed Nov 14, 2024
0 $1.7B
Q2 2024 13F
Filed Aug 14, 2024
0 $1.3B
Q1 2024 13F
Filed May 15, 2024
48 $1.3B
Q4 2023 13F
Filed Feb 14, 2024
0 $1.3B
Q3 2023 13F
Filed Nov 14, 2023
0 $1.4B
Q2 2023 13F
Filed Aug 14, 2023
2 $1.2B
Q1 2023 13F
Filed May 15, 2023
1 $1.2B
Q4 2022 13F
Filed Feb 14, 2023
2 $1.2B
Q3 2022 13F
Filed Nov 14, 2022
2 $1.1B
Q2 2022 13F
Filed Aug 15, 2022
0 $1.0B
Q1 2022 13F
Filed May 16, 2022
0 $1.2B
Q4 2021 13F
Filed Feb 14, 2022
0 $1.3B

12 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2025

Largest Q1 2025 13F positions by reported value
# Holding Reported value % of portfolio
1 XYZ 0.25 11/01/27 BLOCK INC $129.4M 7.92%
2 TDOC 1.25 06/01/27 TELADOC HEALTH INC $117.3M 7.18%
3 IDCC 3.5 06/01/27 INTERDIGITAL INC $86.1M 5.27%
4 NVCR 0 11/01/25 NOVOCURE LTD $72.4M 4.43%
5 SNAP 0.125 03/01/28 SNAP INC $65.6M 4.01%
6 LITE 0.5 12/15/26 LUMENTUM HLDGS INC $63.9M 3.91%
7 HALO 0.25 03/01/27 HALOZYME THERAPEUTICS INC $63.8M 3.9%
8 FIVN 0.5 06/01/25 FIVE9 INC $61.6M 3.77%
9 CNMD 2.25 06/15/27 CONMED CORP $49.1M 3.0%
10 RPD 0.25 03/15/27 RAPID7 INC $47.7M 2.92%
11 DDD 0 11/15/26 3D SYS CORP DEL $46.9M 2.87%
12 NVMI NOVA LTD $44.7M 2.74%
13 653656AB4 NICE LTD $43.1M 2.64%
14 XMTR 1 02/01/27 XOMETRY INC $43.0M 2.63%
15 SRPT 1.25 09/15/27 SAREPTA THERAPEUTICS INC $43.0M 2.63%
16 FSLY 0 03/15/26 FASTLY INC $40.5M 2.48%
17 TYL 0.25 03/15/26 TYLER TEX INDPT SCH DIST $35.8M 2.19%
18 DVAX 2.5 05/15/26 DYNAVAX TECHNOLOGIES CORP $33.0M 2.02%
19 PRGS 1 04/15/26 PROGRESS SOFTWARE CORP $32.3M 1.98%
20 PI 1.125 05/15/27 IMPINJ INC $31.0M 1.9%

Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings